Across three cohorts totaling 12,042 patients with chronic kidney disease, higher resting heart rate (RHR) predicted greater all-cause and cardiovascular mortality, while higher physical activity (PA) was consistently protective. Joint analyses showed the worst outcomes in people with high RHR and low PA, and high PA weakened the mortality link to elevated RHR. Mediation analysis suggested RHR explains part of PA's survival benefit.
The finding fits a large literature showing that resting heart rate, a free, easily measured marker of autonomic balance, tracks cardiovascular risk, and that exercise lowers RHR by boosting vagal tone. What makes this analysis useful is the CKD setting, where cardiovascular death outpaces progression to dialysis and fatigue often discourages movement. The message is practical: a fast pulse is not destiny if activity is high. Still, the design is observational. PA was almost certainly self-reported, which invites recall error, and reverse causation looms large, because sicker patients move less and carry higher heart rates from anemia, inflammation, or heart failure. The mediation result describes statistical partitioning, not proof that lowering RHR drives the benefit, and beta-blockers or other medications may confound RHR. No trial here shows that raising activity lowers mortality in CKD. Editorially, this is confirmatory rather than paradigm-shifting, but it supports a low-cost habit: CKD patients should discuss tailored exercise with their nephrologist and track RHR over time.